S 3729119th CongressIn Committee

PBM Reporting Transparency Act

Standard Summary
Balanced plain-English summary

The PBM Reporting Transparency Act requires the Medicare Payment Advisory Commission to submit two reports to Congress on agreements between pharmacy benefit managers and prescription drug plans and MA-PD plans. The reports would describe trends and patterns, analyze differences in agreements and their effects on enrollee out-of-pocket spending and pharmacy reimbursement, and include recommendations. An initial report is due after data is made available, followed by a final report two years later.

Key Points

  • 1Requires MedPAC to report to Congress on pharmacy benefit manager agreements with prescription drug plans and MA-PD plans.
  • 2Directs analysis of trends, averages, totals, and differences in PBM agreements.
  • 3Examines effects on plan enrollee out-of-pocket spending and average pharmacy reimbursement.
  • 4Requires an initial report and a final follow-up report two years later.
  • 5Allows MedPAC to include recommendations determined appropriate.

Impact Areas

Medicare Part D enrolleesMA-PD plan enrolleesPharmacy benefit managersPharmaciesPrescription drug plansMedPAC and Congress
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026